Search

Your search keyword '"Žáčková D"' showing total 1 results
Start Over Author "Žáčková D" Region europe

Refine your results

1 results on '"Žáčková D"'

1. Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR-final report from AFTER-SKI.

Author

Richter J, Lübking A, Söderlund S, Lotfi K, Markevärn B, Själander A, Stenke L, Deneberg S, Ahlstrand E, Myhr-Eriksson K, Panayiotidis P, Gedde-Dahl T, Žáčková D, Mayer J, Olsson-Strömberg U, Mahon FX, Saussele S, Hjorth-Hansen H, and Koskenvesa P

Subjects
Europe epidemiology, Fusion Proteins, bcr-abl genetics, Humans, Leukemia, Myelogenous, Chronic, BCR-ABL Positive genetics, Leukemia, Myelogenous, Chronic, BCR-ABL Positive pathology, Neoplasm Recurrence, Local chemically induced, Neoplasm Recurrence, Local epidemiology, Prognosis, Remission Induction, Time Factors, Clinical Trials as Topic methods, Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy, Neoplasm Recurrence, Local diagnosis, Protein Kinase Inhibitors adverse effects, Withholding Treatment statistics & numerical data
Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results